跳至主要内容
临床试验/CTRI/2017/06/008811
CTRI/2017/06/008811已完成不适用

Long term uptake study of 3 ug of Hydroxo Vitamin B12 and Cyano Vitamin B12 in Indians adults (IMPROVIT- PART II)

Department of Biotechnology New Delhi India1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2016年4月4日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
54
试验地点
1
主要终点
Reduction in homocysteine due to hydroxocobalamin intake

研究概览

简要总结

The rise in plasma holotranscobalamin is significantly higher and reduction in homocysteine is lower in hydroxocobalamin administered participants than those of cyanocobalamin administered.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Vegetarians with low plasma vitamin B12 in Indian participants.

排除标准

  • Non vegetarians, cancer and the participants consuming vitamin B12 pills and the drugs known to influence vitamin B12 absorption.

结局指标

主要结局

Reduction in homocysteine due to hydroxocobalamin intake

时间窗: Baseline and every week till eight weeks

次要结局

  • Better uptake due to hydroxocobalamin, Increase in holoTC and reduction in Homocysteine(Baseline and every week till eight weeks)

研究者

发起方
Department of Biotechnology New Delhi India
申办方类型
Government funding agency

研究点 (1)

Loading locations...

相似试验